People: GlaxoSmithKline PLC (GSK.L)
27 Aug 2014
Mr. Patrick Vallance is President - Pharmaceuticals R&D of Glaxosmithkline Plc., since January 2012. Prior to his appointment he was Senior Vice President, Medicines Discovery and Development. Patrick joined the company in 2006 as Head of Drug Discovery. He focused the organisation on science that has the best chance of leading to new medicines, and created small, multidisciplinary teams called Discovery Performance Units. He is transforming the way in which we approach late stage clinical trial design and execution. Prior to joining GSK Patrick was a clinical academic at University College London. Patrick is a member of the Board of the Agency for Science, Technology & Research (A*STAR) and is a director of Genome Research Limited.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|